Page 17 - பல்கலைக்கழகம் மருத்துவமனை ஸுரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First Patient Treated in Polyganics ENCASE II Trial for Innovative Dura Sealant Patch, LIQOSEAL

Posted on 210 Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, today announced treatment of the first patient in its ENCASE II clinical trial for LIQOSEAL ®. LIQOSEAL ® is an easy-to-use, synthetic dura sealant patch indicated for use as an adjunct to standard methods of cranial dural repair, to provide watertight closure of the dura mater and reduce cerebrospinal fluid (CSF) leakage. In addition, LIQOSEAL ® also supports regeneration of the dura mater by acting as a scaffold for new fibrotic layer formation (‘neodura’). ENCASE II is randomized, two-arm, multicenter study, evaluating the safety and efficacy of LIQOSEAL ® in reducing intra- or post-operative CSF leakage in patients undergoing elective cranial surgery. The trial will involve 228 patients, enrolled and treated at up to 20 clinical centres across the US and Europe. Patients wi

New mexicoUnited statesRudy mareelAndrew carlsonPaul roosMarleen schoonenTristan van doormaalNeurosurg hagerstownUniversity hospital zurichUniversity medical centerUniversity of new mexico hospitals in albuquerqueCorporate communication affairsNew mexico hospitalsGlobal coordinating investigatorCoordinating investigatorPeripheral nerve repair

Type 2 diabetes medication shown to benefit asthma patients

E-Mail IMAGE: Katherine Cahill, MD, medical director of Clinical Asthma Research in the Division of Allergy, Pulmonary, and Critical Care Medicine at Vanderbilt University Medical Center. view more Credit: Vanderbilt University Medical Center Type 2 diabetes patients who also have asthma are benefitting from a diabetes medication, typically given to help the pancreas produce more insulin, that also improves asthma symptoms and may reduce lung and airway inflammation. These types of medication GLP-1 receptor agonists are a newer class of FDA-approved therapeutics that are generally used in addition to metformin for control of blood sugar or to induce weight loss in patients with obesity.

United statesKevin niswenderKatherine cahillShinji tokiMelissa bloodworthDivision of allergyUniversity hospital zurichVanderbilt university medical centerNational institutes of healthNational institute of allergyClinical asthma researchHarvard medical schoolAmerican journalCritical careCritical care medicineStokes peebles

Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances

May 21, 2021 Transcatheter therapies for tricuspid valve disease continue to gain momentum, as evidenced by three studies presented at this week’s EuroPCR 2021: TRISCEND, TriBAND, and CLASP TR. On the whole, the early data suggest these devices are a viable treatment for tricuspid regurgitation (TR), investigators told the meeting’s virtual audience, yet they also speak to the diverse approaches annular reduction, transcatheter edge-to-edge repair (TEER), and valve replacement aimed at addressing this clinical niche. All three are manufactured by Edwards Lifesciences: Thirty-day data from TRISCEND make the case for valve replacement, specifically with the Evoque device, in patients with symptomatic and at least moderate TR.

New yorkUnited statesUniversity hospitalMackram eleidGeorg nickenigSusheel kodaliThomas modineTrialign mitralignMara gavazzoniEdwards lifesciencesMd university hospital bonnAmerican college of cardiologyMd university hospital zurichPresbyterian columbia university irving medical centerTrivalve registryAmerican college

Hohe Erwartungen: Schweizer Corona-Medikamente stehen kurz vor dem Durchbruch

Hohe Erwartungen: Schweizer Corona-Medikamente stehen kurz vor dem Durchbruch
gmx.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gmx.ch Daily Mail and Mail on Sunday newspapers.

Switzerland generalInfectiologist brownHer developmentUniversity hospital zurichEuropean medicines agencyA research labAgency for healthHigh expectationsTwo swissSwiss vaccineTwo swiss takeResearch labMutations actTake be drugFull speedFinancing not

Geldanlage - Mit Glencore schürfen Sie an der Börse Geld – und vier weitere Börsentipps

Geldanlage - Mit Glencore schürfen Sie an der Börse Geld – und vier weitere Börsentipps
luzernerzeitung.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from luzernerzeitung.ch Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomFrancois blochLondon exchangeExchange moneyHer holdingUniversity hospital zurichMonetary system with mine theySwitzerland weekendClock remember print exclusiveSubscribers unleashedEarly yearsOperating profitNew record statusUnder reviewApplicable they